Literature DB >> 16093428

Mechanical strain increases SPARC levels in podocytes: implications for glomerulosclerosis.

Raghu V Durvasula1, Stuart J Shankland.   

Abstract

Glomerular capillary hypertension is a final common pathway to glomerulosclerosis. Because podocyte loss is an early event in the development of glomerulosclerosis, it is logical that the deleterious effects of glomerular capillary hypertension involve podocyte injury. Yet, the mechanisms by which elevated intraglomerular pressure is translated into a maladaptive podocyte response remain poorly understood. Secreted protein acidic and rich in cysteine (SPARC) is a matricellular protein activated in various disease states of the podocyte and accelerates renal injury, as evidenced by the milder course of experimental diabetic nephropathy in SPARC-null mice compared with diabetic SPARC wild-type mice. Accordingly, we tested the hypothesis that mechanical strain activates SPARC in podocytes and thus is a putative mediator of podocyte injury in states of intraglomerular capillary hypertension. Conditionally immortalized mouse podocytes were subjected to 10% cyclical stretch while nonstretched cells served as controls. SPARC levels were measured in whole cell lysate and cell media. Immunostaining was performed for SPARC in an experimental model of glomerular capillary hypertension. Our results demonstrate cyclical stretch of podocytes markedly increased SPARC levels in cell lysate, through activation of p38, as well as secreted SPARC. Relevance was shown by demonstrating increased podocyte staining for SPARC in the uninephrectomized spontaneously hypertensive rat. In conclusion, we have made the novel observation that mechanical forces characteristic of states of glomerular capillary hypertension lead to increased levels of SPARC in podocytes. We speculate that the increase in SPARC may be maladaptive and lead to a progressive reduction in podocyte number, thus fueling the future development of glomerulosclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16093428     DOI: 10.1152/ajprenal.00393.2004

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  16 in total

1.  Endothelin A receptor activation on mesangial cells initiates Alport glomerular disease.

Authors:  Brianna Dufek; Daniel T Meehan; Duane Delimont; Linda Cheung; Michael Anne Gratton; Grady Phillips; Wenping Song; Shiguang Liu; Dominic Cosgrove
Journal:  Kidney Int       Date:  2016-04-27       Impact factor: 10.612

Review 2.  Stressed podocytes-mechanical forces, sensors, signaling and response.

Authors:  Karlhans Endlich; Felix Kliewe; Nicole Endlich
Journal:  Pflugers Arch       Date:  2017-07-07       Impact factor: 3.657

Review 3.  Congenital ureteropelvic junction obstruction: human disease and animal models.

Authors:  Julie Klein; Julien Gonzalez; Mathieu Miravete; Cécile Caubet; Rana Chaaya; Stéphane Decramer; Flavio Bandin; Jean-Loup Bascands; Bénédicte Buffin-Meyer; Joost P Schanstra
Journal:  Int J Exp Pathol       Date:  2010-07-30       Impact factor: 1.925

Review 4.  Role of biomechanical forces in hyperfiltration-mediated glomerular injury in congenital anomalies of the kidney and urinary tract.

Authors:  Tarak Srivastava; Ganesh Thiagarajan; Uri S Alon; Ram Sharma; Ashraf El-Meanawy; Ellen T McCarthy; Virginia J Savin; Mukut Sharma
Journal:  Nephrol Dial Transplant       Date:  2017-05-01       Impact factor: 5.992

Review 5.  Hyperfiltration-associated biomechanical forces in glomerular injury and response: Potential role for eicosanoids.

Authors:  Mukut Sharma; Ram Sharma; Ellen T McCarthy; Virginia J Savin; Tarak Srivastava
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-01-17       Impact factor: 3.072

6.  Flow-induced prostaglandin E2 release regulates Na and K transport in the collecting duct.

Authors:  Daniel Flores; Yu Liu; Wen Liu; Lisa M Satlin; Rajeev Rohatgi
Journal:  Am J Physiol Renal Physiol       Date:  2012-06-13

7.  Biomechanical strain causes maladaptive gene regulation, contributing to Alport glomerular disease.

Authors:  Daniel T Meehan; Duane Delimont; Linda Cheung; Marisa Zallocchi; Steven C Sansom; J David Holzclaw; Velidi Rao; Dominic Cosgrove
Journal:  Kidney Int       Date:  2009-08-26       Impact factor: 10.612

8.  Microarray and bioinformatics analysis of gene expression in experimental membranous nephropathy.

Authors:  Peter V Hauser; Paul Perco; Irmgard Mühlberger; Jeffrey Pippin; Mary Blonski; Bernd Mayer; Charles E Alpers; Rainer Oberbauer; Stuart J Shankland
Journal:  Nephron Exp Nephrol       Date:  2009-04-18

9.  SPARC accelerates disease progression in experimental crescentic glomerulonephritis.

Authors:  Amy N Sussman; Tong Sun; Ronald M Krofft; Raghu V Durvasula
Journal:  Am J Pathol       Date:  2009-03-26       Impact factor: 4.307

Review 10.  Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment.

Authors:  Judy Savige
Journal:  J Physiol       Date:  2014-08-08       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.